Diabetic foot
> risk assessment


  • Home
  • Trauma
    • Pilon fractures
    • Ankle fractures
    • Talus fractures
    • Calcaneal fractures
    • Lisfranc injuries
    • 5th metatarsal fractures
    • Achilles tendon rupture
  • General
    • Diabetic foot
    • Rheumatoid foot
    • Pes cavus
    • Flatfoot (general)
  • Ankle
    • Instability
    • Impingement
    • Osteochondral lesions
    • Osteoarthritis
  • Hind/midfoot
    • Tarsal joint problems
    • Heel pain/plantar fasciitis
    • Tarsal tunnel syndrome
    • Sinus tarsi syndrome
    • Ganglia
  • Tendons
    • Achilles tendonopathy
    • Tibialis posterior tendonopathy/adult acquired flatfoot
    • Peroneal tendon problems
  • First ray
    • Hallux valgus
    • Hallux rigidus
    • Hallux varus
    • Sesamoid problems
    • Ingrowing toenail
    • Subungual exostosis
  • Lesser rays
    • Lesser toe problems
    • Metatarsalgia
    • Metatarsophalangeal instability
    • Interdigital neuroma
    • Freiberg's disease
    • Bunionette
  • quickGuides
    • Heel pain
    • Hallux valgus

Diabetic foot

  • introduction
  • pathology
    • ulcers
    • Charcot
  • classification
    • ulcers
    • Charcot
  • epidemiology
  • clinical assessment
    • history
    • examination
    • risk assessment (this page)
  • investigation
  • management
    • prevention
    • simple ulcers
    • ulcers + infection
    • early Charcot
    • late Charcot deformities

Last evidence check October 2015

The following increase the risk of major complications in the diabetic foot:

  • Previous ulceration
  • Neuropathy (loss of pressure sensation to 10g neurofilament)
  • Duration of diabetes
  • Poor metabolic control
  • Poor foot care
  • Ill-fitting shoes
  • Deformity
  • Tight Achilles tendon

The International Working Group on the Diabetic Foot produced a risk stratification, which was studied in a prospective cohort of 225 patients followed for 3 years (Peters et al 2001).

Group

Criteria

Ulceration rate (%)

Amputation rate (%)

0

no neuropathy

5

0

1

neuropathy, no deformity or vascular disease

14

0

2

neuropathy and deformity or vascular disease

19

3

3

previous ulcer or amputation

55

21

This was modified in the light of further work on outcomes (Lavery 2008), reflecting the independently higher risk in patients with vascular disease:

  • group 0 - no neuropathy or vascular disease
  • group 1 - neuropathy, no vascular disease or deformity
  • group 2A - neuropathy and deformity, no vascular disease
  • group 2B - vascular disease
  • group 3A - previous ulcer
  • group 3B - previous amputation

Montero-Soares (2012) reported a prospective study of 364 diabetic patients without ulcers who were followed up for 1 year or until an ulcer occurred. The IWGDF risk stratification system and four other systems (the University of Texas, American Diabetic Association, SIGN and Seattle systems) were applied prospectively. Although there was no statistically significant difference in the power of the different systems to predict the occurrence of an ulcer, the area under the receiver operating characteristic curve was largest for the IWGDF system.